UnitedHealth Group (NYSE:UNH – Get Free Report) had its price target reduced by investment analysts at Morgan Stanley from $563.00 to $374.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the healthcare conglomerate’s stock. Morgan Stanley’s target price would suggest a potential upside of 36.52% from the stock’s previous close.
Several other equities analysts have also recently commented on the stock. KeyCorp lowered their price target on shares of UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating on the stock in a report on Wednesday. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. Finally, Truist Financial decreased their price objective on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a report on Monday, April 21st. Six analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $508.38.
Get Our Latest Analysis on UNH
UnitedHealth Group Stock Performance
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company posted $6.91 EPS. On average, equities research analysts forecast that UnitedHealth Group will post 29.54 EPS for the current year.
Institutional Trading of UnitedHealth Group
Several hedge funds have recently modified their holdings of UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth $28,000. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the period. Finally, Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group in the fourth quarter worth $30,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- How to Use the MarketBeat Stock Screener
- Walmart Stock Alert: Big Price Move Expected Soon
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- What Does Downgrade Mean in Investing?
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.